| Year |
Citation |
Score |
| 2021 |
Focosi D, Franchini M, Pirofski LA, Maggi F, Casadevall A. Is SARS-CoV-2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody-based therapeutics? Reviews in Medical Virology. e2314. PMID 34861088 DOI: 10.1002/rmv.2314 |
0.306 |
|
| 2021 |
Herman JD, Wang C, Loos C, Yoon H, Rivera J, Eugenia Dieterle M, Haslwanter D, Jangra RK, Bortz RH, Bar KJ, Julg B, Chandran K, Lauffenburger D, Pirofski LA, Alter G. Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response. Nature Communications. 12: 6853. PMID 34824251 DOI: 10.1038/s41467-021-27201-y |
0.322 |
|
| 2021 |
Babb R, Doyle CR, Pirofski LA. Isolation and Characterization of Human Monoclonal Antibodies to Pneumococcal Capsular Polysaccharide 3. Microbiology Spectrum. e0144621. PMID 34756090 DOI: 10.1128/Spectrum.01446-21 |
0.396 |
|
| 2021 |
Ozdilek A, Huang J, Babb R, Paschall AV, Middleton DR, Duke JA, Pirofski LA, Mousa JJ, Avci FY. A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies. Mbio. e0080021. PMID 34061603 DOI: 10.1128/mBio.00800-21 |
0.35 |
|
| 2021 |
Herman JD, Wang C, Loos C, Yoon H, Rivera J, Dieterle ME, Haslwanter D, Jangra RK, Bortz RH, Bar KJ, Julg B, Chandran K, Lauffenburger D, Pirofski LA, Alter G. Functional Antibodies in COVID-19 Convalescent Plasma. Medrxiv : the Preprint Server For Health Sciences. PMID 33758875 DOI: 10.1101/2021.03.08.21253157 |
0.333 |
|
| 2020 |
Casadevall A, Joyner MJ, Pirofski LA. Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. The New England Journal of Medicine. 384. PMID 33378610 DOI: 10.1056/NEJMc2033787#sa1 |
0.313 |
|
| 2020 |
Casadevall A, Joyner MJ, Pirofski LA. Implications of COVI-19 antibody dynamics for immunity and convalescent plasma therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32805024 DOI: 10.1093/Cid/Ciaa1213 |
0.364 |
|
| 2020 |
Casadevall A, Joyner MJ, Pirofski LA. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. The Journal of Clinical Investigation. PMID 32634126 DOI: 10.1172/Jci139760 |
0.407 |
|
| 2020 |
Trevijano-Contador N, Pianalto KM, Nichols CB, Zaragoza O, Alspaugh JA, Pirofski LA. Human IgM inhibits the formation of Titan-like cells in . Infection and Immunity. PMID 31988178 DOI: 10.1128/Iai.00046-20 |
0.378 |
|
| 2020 |
Godbout EJ, Madaline T, Casadevall A, Bearman G, Pirofski LA. The damage response framework and infection prevention: From concept to bedside. Infection Control and Hospital Epidemiology. 1-5. PMID 31915082 DOI: 10.1017/Ice.2019.354 |
0.313 |
|
| 2019 |
Yoon HA, Felsen U, Wang T, Pirofski LA. Cryptococcus neoformans infection in Human Immunodeficiency Virus (HIV)-infected and HIV-uninfected patients at an inner-city tertiary care hospital in the Bronx. Medical Mycology. PMID 31342058 DOI: 10.1093/Mmy/Myz082 |
0.347 |
|
| 2019 |
Trevijano-Contador N, Pirofski L. Antibody immunity and natural resistance to cryptococcosis. Current Tropical Medicine Reports. 6: 50-54. PMID 31134140 DOI: 10.1007/S40475-019-00174-1 |
0.45 |
|
| 2019 |
Hlupeni A, Nakouzi A, Wang T, Boyd KF, Makadzange TA, Ndhlovu CE, Pirofski LA. Antibody Responses in HIV-Infected Patients With Advanced Immunosuppression and Asymptomatic Cryptococcal Antigenemia. Open Forum Infectious Diseases. 6: ofy333. PMID 30648127 DOI: 10.1093/Ofid/Ofy333 |
0.391 |
|
| 2018 |
Doyle CR, Moon JY, Daily JP, Wang T, Pirofski LA. A capsular polysaccharide-specific antibody alters gene expression during nasopharyngeal colonization of mice. Infection and Immunity. PMID 29735523 DOI: 10.1128/Iai.00300-18 |
0.311 |
|
| 2018 |
Babb R, Pirofski L. 647. Characterization and Development of Human Monoclonal Antibodies to Pneumococcal Serotype 3 Open Forum Infectious Diseases. 5: S234-S235. DOI: 10.1093/Ofid/Ofy210.654 |
0.444 |
|
| 2018 |
Contador NT, Pirofski L. 2034. Natural Antibodies Affects the Formation of Titan Cells in Cryptococcus neoformans In Vitro Open Forum Infectious Diseases. 5: S593-S593. DOI: 10.1093/Ofid/Ofy210.1690 |
0.395 |
|
| 2017 |
Dufaud C, Rivera J, Rohatgi S, Pirofski LA. Naïve B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1(-/-) mice. Virulence. 0. PMID 28837391 DOI: 10.1080/21505594.2017.1370529 |
0.346 |
|
| 2017 |
Babb R, Pirofski LA. Help is on the way: monoclonal antibody therapy for multi-drug resistant bacteria. Virulence. 0. PMID 28306387 DOI: 10.1080/21505594.2017.1306620 |
0.348 |
|
| 2017 |
Schumann B, Hahm HS, Parameswarappa SG, Reppe K, Wahlbrink A, Govindan S, Kaplonek P, Pirofski LA, Witzenrath M, Anish C, Pereira CL, Seeberger PH. A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine. Science Translational Medicine. 9. PMID 28275152 DOI: 10.1126/Scitranslmed.Aaf5347 |
0.446 |
|
| 2017 |
Kelly B, Rivera J, Pirofski L. Oropharyngeal Bacterial Community Composition Correlates with Baseline and Post-Vaccination Pneumococcal Polysaccharide Antibody Levels in HIV-Infected Subjects Open Forum Infectious Diseases. 4: S234-S234. DOI: 10.1093/Ofid/Ofx163.493 |
0.412 |
|
| 2016 |
Parameswarappa SG, Reppe K, Geissner A, Ménová P, Govindan S, Calow AD, Wahlbrink A, Weishaupt MW, Monnanda BP, Bell RL, Pirofski LA, Suttorp N, Sander LE, Witzenrath M, Pereira CL, et al. A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection. Cell Chemical Biology. PMID 27818299 DOI: 10.1016/J.Chembiol.2016.09.016 |
0.318 |
|
| 2016 |
De La Rosa I, Munjal IM, Rodriguez-Barradas M, Yu X, Pirofski LA, Mendoza D. Protease inhibitors do not affect antibody responses to pneumococcal vaccination. Clinical and Vaccine Immunology : Cvi. PMID 27074938 DOI: 10.1128/CVI.00026-16 |
0.344 |
|
| 2016 |
Doyle CR, Pirofski LA. Reduction of Streptococcus pneumoniae Colonization and Dissemination by a Nonopsonic Capsular Polysaccharide Antibody. Mbio. 7. PMID 26838726 DOI: 10.1128/Mbio.02260-15 |
0.444 |
|
| 2016 |
Yoon HA, Kuniholm MH, Nakouzi A, Chang C, French M, Pirofski L. Association of Decreased Cryptococcal Antibody Levels With Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw194.64 |
0.373 |
|
| 2016 |
Yoon HA, Pirofski L. Clinical Features of Crytococcus neoformans Infection in Human Immunodeficiency Virus (HIV)–Infected and HIV-Uninfected Patients Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1308 |
0.326 |
|
| 2015 |
Rodriguez-Barradas MC, Serpa JA, Munjal I, Mendoza D, Rueda AM, Mushtaq M, Pirofski LA. Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial. The Journal of Infectious Diseases. 211: 1703-11. PMID 25538270 DOI: 10.1093/infdis/jiu819 |
0.323 |
|
| 2013 |
Szymczak WA, Davis MJ, Lundy SK, Dufaud C, Olszewski M, Pirofski LA. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection. Mbio. 4. PMID 23820392 DOI: 10.1128/mBio.00265-13 |
0.355 |
|
| 2013 |
Vernatter J, Pirofski LA. Current concepts in host-microbe interaction leading to pneumococcal pneumonia. Current Opinion in Infectious Diseases. 26: 277-83. PMID 23571695 DOI: 10.1097/Qco.0B013E3283608419 |
0.321 |
|
| 2012 |
Rohatgi S, Pirofski LA. Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection. Journal of Immunology (Baltimore, Md. : 1950). 189: 5820-30. PMID 23175699 DOI: 10.4049/Jimmunol.1201514 |
0.347 |
|
| 2012 |
Hofmeyer KA, Scandiuzzi L, Ghosh K, Pirofski LA, Zang X. Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection. Journal of Immunology (Baltimore, Md. : 1950). 189: 3054-63. PMID 22855708 DOI: 10.4049/Jimmunol.1200701 |
0.319 |
|
| 2012 |
Casadevall A, Pirofski LA. Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host & Microbe. 11: 447-56. PMID 22607798 DOI: 10.1016/J.Chom.2012.04.004 |
0.381 |
|
| 2012 |
Weber S, Tian H, van Rooijen N, Pirofski LA. A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice. Infection and Immunity. 80: 1314-22. PMID 22290146 DOI: 10.1128/Iai.06081-11 |
0.709 |
|
| 2012 |
Marr KA, Datta K, Pirofski LA, Barnes R. Cryptococcus gattii infection in healthy hosts: a sentinel for subclinical immunodeficiency? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 153-4. PMID 22075791 DOI: 10.1093/Cid/Cir756 |
0.313 |
|
| 2011 |
Yano M, Gohil S, Coleman JR, Manix C, Pirofski LA. Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing. Mbio. 2. PMID 21917597 DOI: 10.1128/mBio.00176-11 |
0.392 |
|
| 2011 |
Seyoum B, Yano M, Pirofski LA. The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response. Vaccine. 29: 8002-11. PMID 21864623 DOI: 10.1016/j.vaccine.2011.08.064 |
0.349 |
|
| 2011 |
Serpa JA, Valayam J, Musher DM, Rossen RD, Pirofski LA, Rodriguez-Barradas MC. V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons. Clinical and Vaccine Immunology : Cvi. 18: 362-6. PMID 21228144 DOI: 10.1128/CVI.00408-10 |
0.33 |
|
| 2011 |
Weber SE, Tian H, Pirofski LA. CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice. Journal of Immunology (Baltimore, Md. : 1950). 186: 432-42. PMID 21135172 DOI: 10.4049/Jimmunol.1001963 |
0.632 |
|
| 2011 |
Yano M, Pirofski LA. Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8. Clinical and Vaccine Immunology : Cvi. 18: 59-66. PMID 21068211 DOI: 10.1128/Cvi.00368-10 |
0.487 |
|
| 2010 |
Fabrizio K, Manix C, Tian H, van Rooijen N, Pirofski LA. The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages. Vaccine. 28: 7542-50. PMID 20800700 DOI: 10.1016/J.Vaccine.2010.08.061 |
0.778 |
|
| 2010 |
Pirofski LA. Why antibodies disobey the Hippocratic Oath and end up doing harm: a new clue. The Journal of Clinical Investigation. 120: 3099-102. PMID 20739749 DOI: 10.1172/Jci44312 |
0.381 |
|
| 2010 |
Subramaniam KS, Datta K, Quintero E, Manix C, Marks MS, Pirofski LA. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. Journal of Immunology (Baltimore, Md. : 1950). 184: 5755-67. PMID 20404271 DOI: 10.4049/Jimmunol.0901638 |
0.709 |
|
| 2010 |
Fabrizio K, Manix C, Guimaraes AJ, Nosanchuk JD, Pirofski LA. Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo. Clinical and Vaccine Immunology : Cvi. 17: 713-21. PMID 20200186 DOI: 10.1128/Cvi.00410-09 |
0.787 |
|
| 2010 |
Subramaniam KS, Datta K, Marks MS, Pirofski LA. Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans. Infection and Immunity. 78: 441-52. PMID 19901068 DOI: 10.1128/Iai.00506-09 |
0.724 |
|
| 2009 |
Subramaniam K, Metzger B, Hanau LH, Guh A, Rucker L, Badri S, Pirofski LA. IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status. The Journal of Infectious Diseases. 200: 244-51. PMID 19527168 DOI: 10.1086/599318 |
0.632 |
|
| 2009 |
Alvarez M, Burn T, Luo Y, Pirofski LA, Casadevall A. The outcome of Cryptococcus neoformans intracellular pathogenesis in human monocytes. Bmc Microbiology. 9: 51. PMID 19265539 DOI: 10.1186/1471-2180-9-51 |
0.34 |
|
| 2009 |
Tian H, Weber S, Thorkildson P, Kozel TR, Pirofski LA. Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice. Infection and Immunity. 77: 1502-13. PMID 19168739 DOI: 10.1128/Iai.01075-08 |
0.69 |
|
| 2008 |
Datta K, Lees A, Pirofski LA. Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan. Clinical and Vaccine Immunology : Cvi. 15: 1176-87. PMID 18524882 DOI: 10.1128/CVI.00130-08 |
0.352 |
|
| 2007 |
Casadevall A, Pirofski LA. Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma. Infection and Immunity. 75: 5074-8. PMID 17709417 DOI: 10.1128/Iai.01001-07 |
0.41 |
|
| 2007 |
Fabrizio K, Groner A, Boes M, Pirofski LA. A human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infection. Clinical and Vaccine Immunology : Cvi. 14: 382-90. PMID 17301214 DOI: 10.1128/Cvi.00374-06 |
0.79 |
|
| 2007 |
Marks M, Burns T, Abadi M, Seyoum B, Thornton J, Tuomanen E, Pirofski LA. Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infection and Immunity. 75: 1586-97. PMID 17296760 DOI: 10.1128/Iai.01579-06 |
0.639 |
|
| 2007 |
García-Suárez Mdel M, Flórez N, Astudillo A, Vázquez F, Villaverde R, Fabrizio K, Pirofski LA, Méndez FJ. The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model. Respiratory Research. 8: 3. PMID 17257395 DOI: 10.1186/1465-9921-8-3 |
0.73 |
|
| 2007 |
Tian H, Groner A, Boes M, Pirofski LA. Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice. Infection and Immunity. 75: 1643-50. PMID 17220309 DOI: 10.1128/Iai.01371-06 |
0.408 |
|
| 2006 |
Casadevall A, Pirofski LA. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Advances in Immunology. 91: 1-44. PMID 16938537 DOI: 10.1016/S0065-2776(06)91001-3 |
0.302 |
|
| 2006 |
Jalali Z, Ng L, Singh N, Pirofski LA. Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation. Clinical and Vaccine Immunology : Cvi. 13: 740-6. PMID 16829610 DOI: 10.1128/Cvi.00139-06 |
0.335 |
|
| 2006 |
Pirofski LA. Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans. Infection and Immunity. 74: 3079-84. PMID 16714535 DOI: 10.1128/Iai.00431-06 |
0.326 |
|
| 2006 |
Datta K, Pirofski LA. Towards a vaccine for Cryptococcus neoformans: principles and caveats. Fems Yeast Research. 6: 525-36. PMID 16696648 DOI: 10.1111/J.1567-1364.2006.00073.X |
0.384 |
|
| 2005 |
Subramaniam K, French N, Pirofski LA. Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans. Clinical and Diagnostic Laboratory Immunology. 12: 1168-76. PMID 16210479 DOI: 10.1128/Cdli.12.10.1168-1176.2005 |
0.711 |
|
| 2005 |
Casadevall A, Pirofski LA. The potential of antibody-mediated immunity in the defence against biological weapons. Expert Opinion On Biological Therapy. 5: 1359-72. PMID 16197341 DOI: 10.1517/14712598.5.10.1359 |
0.312 |
|
| 2005 |
Burns T, Abadi M, Pirofski LA. Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide. Infection and Immunity. 73: 4530-8. PMID 16040964 DOI: 10.1128/Iai.73.8.4530-4538.2005 |
0.645 |
|
| 2005 |
Casadevall A, Pirofski L. Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans Current Molecular Medicine. 5: 421-433. PMID 15977998 DOI: 10.2174/1566524054022567 |
0.436 |
|
| 2005 |
Buchwald UK, Lees A, Steinitz M, Pirofski LA. A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice. Infection and Immunity. 73: 325-33. PMID 15618169 DOI: 10.1128/Iai.73.1.325-333.2005 |
0.502 |
|
| 2004 |
Casadevall A, Pirofski LA. New concepts in antibody-mediated immunity. Infection and Immunity. 72: 6191-6. PMID 15501743 DOI: 10.1128/Iai.72.11.6191-6196.2004 |
0.334 |
|
| 2004 |
Chang Q, Abadi J, Rosenberg M, Pirofski LA. VH3 gene expression in children with HIV infection. The Journal of Infection. 49: 274-82. PMID 15474624 DOI: 10.1016/J.Jinf.2004.04.007 |
0.318 |
|
| 2004 |
Maitta RW, Datta K, Pirofski LA. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan. Vaccine. 22: 4062-8. PMID 15364457 DOI: 10.1016/J.Vaccine.2004.03.060 |
0.725 |
|
| 2004 |
Maitta RW, Datta K, Chang Q, Luo RX, Witover B, Subramaniam K, Pirofski LA. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles. Infection and Immunity. 72: 4810-8. PMID 15271943 DOI: 10.1128/Iai.72.8.4810-4818.2004 |
0.789 |
|
| 2004 |
Dadachova E, Burns T, Bryan RA, Apostolidis C, Brechbiel MW, Nosanchuk JD, Casadevall A, Pirofski L. Feasibility of radioimmunotherapy of experimental pneumococcal infection. Antimicrobial Agents and Chemotherapy. 48: 1624-9. PMID 15105113 DOI: 10.1128/Aac.48.5.1624-1629.2004 |
0.664 |
|
| 2004 |
Maitta RW, Datta K, Lees A, Belouski SS, Pirofski LA. Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice. Infection and Immunity. 72: 196-208. PMID 14688097 DOI: 10.1128/Iai.72.1.196-208.2004 |
0.737 |
|
| 2003 |
Burns T, Zhong Z, Steinitz M, Pirofski LA. Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharide. Infection and Immunity. 71: 6775-83. PMID 14638763 DOI: 10.1128/Iai.71.12.6775-6783.2003 |
0.638 |
|
| 2003 |
Casadevall A, Pirofski LA. Antibody-mediated regulation of cellular immunity and the inflammatory response. Trends in Immunology. 24: 474-8. PMID 12967670 DOI: 10.1016/S1471-4906(03)00228-X |
0.325 |
|
| 2003 |
Subramaniam KS, Segal R, Lyles RH, Rodriguez-Barradas MC, Pirofski LA. Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy. The Journal of Infectious Diseases. 187: 758-68. PMID 12599049 DOI: 10.1086/368331 |
0.711 |
|
| 2003 |
Navoa JA, Laal S, Pirofski LA, McLean GR, Dai Z, Robbins JB, Schneerson R, Casadevall A, Glatman-Freedman A. Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan. Clinical and Diagnostic Laboratory Immunology. 10: 88-94. PMID 12522045 DOI: 10.1128/Cdli.10.1.88-94.2003 |
0.354 |
|
| 2002 |
Chang Q, Zhong Z, Lees A, Pekna M, Pirofski L. Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin loci Infection and Immunity. 70: 4977-4986. PMID 12183544 DOI: 10.1128/Iai.70.9.4977-4986.2002 |
0.5 |
|
| 2002 |
Casadevall A, Feldmesser M, Pirofski LA. Induced humoral immunity and vaccination against major human fungal pathogens. Current Opinion in Microbiology. 5: 386-91. PMID 12160857 DOI: 10.1016/S1369-5274(02)00337-5 |
0.341 |
|
| 2001 |
Pirofski La. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens Trends in Microbiology. 9: 445-451. PMID 11553457 DOI: 10.1016/S0966-842X(01)02134-5 |
0.402 |
|
| 2001 |
Casadevall A, Pirofski LA. Adjunctive immune therapy for fungal infections Clinical Infectious Diseases. 33: 1048-1056. PMID 11528579 DOI: 10.1086/322710 |
0.375 |
|
| 2001 |
Fleuridor R, Lees A, Pirofski LA. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Crytococcus neoformans infection Journal of Immunology. 166: 1087-1096. PMID 11145689 DOI: 10.4049/Jimmunol.166.2.1087 |
0.758 |
|
| 2000 |
Chang Q, Abadi J, Alpert P, Pirofski La. A pneumococcal capsular polysaccharide vaccine induces a repertoire shift with increased V(H)3 expression in peripheral B cells from human immunodeficiency virus (HIV)-uninfected but not HIV-infected persons Journal of Infectious Diseases. 181: 1313-1321. PMID 10762563 DOI: 10.1086/315405 |
0.302 |
|
| 2000 |
Russell ND, Corvalan JR, Gallo ML, Davis CG, Pirofski La. Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci. Infection and Immunity. 68: 1820-6. PMID 10722569 DOI: 10.1128/Iai.68.4.1820-1826.2000 |
0.539 |
|
| 1999 |
Fleuridor R, Lyles RH, Pirofski LA. Quantitative and qualitative differences in the serum antibody profiles of human immunodeficiency virus-infected persons with and without Cryptococcus neoformans meningitis Journal of Infectious Diseases. 180: 1526-1535. PMID 10515812 DOI: 10.1086/315102 |
0.747 |
|
| 1999 |
Abadi J, Pirofski LA. Antibodies reactive with the cryptococcal capsular polysaccharide glucuronoxylomannan are present in sera from children with and without human immunodeficiency virus infection Journal of Infectious Diseases. 180: 915-919. PMID 10438394 DOI: 10.1086/314953 |
0.418 |
|
| 1999 |
Zhong Z, Burns T, Chang Q, Carroll M, Pirofski L. Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide. Infection and Immunity. 67: 4119-27. PMID 10417182 DOI: 10.1128/Iai.67.8.4119-4127.1999 |
0.666 |
|
| 1999 |
Chen LC, Goldman DL, Doering TL, Pirofski La, Casadevall A. Antibody response to Cryptococcus neoformans proteins in rodents and humans. Infection and Immunity. 67: 2218-24. PMID 10225877 DOI: 10.1128/Iai.67.5.2218-2224.1999 |
0.409 |
|
| 1999 |
Abadi J, Nachman S, Kressel AB, Pirofski LA. Cryptococcosis in children with AIDS Clinical Infectious Diseases. 28: 309-313. PMID 10064249 DOI: 10.1086/515130 |
0.301 |
|
| 1999 |
Chen L, Goldman DL, Doering TL, Pirofski L, Casadevall A. Antibody Response to Cryptococcus neoformans Proteins in Rodents and Humans Infection and Immunity. 67: 2218-2224. DOI: 10.1128/iai.67.5.2218-2224.1999 |
0.409 |
|
| 1998 |
Fleuridor R, Zhong Z, Pirofski LA. A human IgM monoclonal antibody prolongs survival of mice with lethal cryptococcosis Journal of Infectious Diseases. 178: 1213-1216. PMID 9806064 DOI: 10.1086/515688 |
0.773 |
|
| 1998 |
Abadi J, Friedman J, Mageed RA, Jefferis R, Rodriguez-Barradas MC, Pirofski LA. Human antibodies elicited by a pneumococcal vaccine express ldiotypic determinants indicative of V(H)3 gene segment usage Journal of Infectious Diseases. 178: 707-716. PMID 9728539 DOI: 10.1086/515369 |
0.493 |
|
| 1998 |
Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski LA, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrobial Agents and Chemotherapy. 42: 1437-46. PMID 9624491 DOI: 10.1128/Aac.42.6.1437 |
0.362 |
|
| 1998 |
Zhong Z, Pirofski LA. Antifungal activity of a human antiglucuronoxylomannan antibody Clinical and Diagnostic Laboratory Immunology. 5: 58-64. PMID 9455881 DOI: 10.1128/Cdli.5.1.58-64.1998 |
0.414 |
|
| 1997 |
Abadi J, Zhong Z, Dobroszycki J, Pirofski LA. FcγRIIa polymorphism in human immunodeficiency virus-infected children with invasive pneumococcal disease Pediatric Research. 42: 259-262. PMID 9284262 DOI: 10.1203/00006450-199709000-00002 |
0.36 |
|
| 1997 |
Zhang H, Zhong Z, Pirofski LA. Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody Infection and Immunity. 65: 1158-1164. PMID 9119446 DOI: 10.1128/Iai.65.4.1158-1164.1997 |
0.453 |
|
| 1996 |
Pirofski LA, Casadevall A. Cryptococcus neoformans: Paradigm for the role of antibody immunity against fungi? Zentralblatt Fur Bakteriologie. 284: 475-495. PMID 8899968 DOI: 10.1016/S0934-8840(96)80001-6 |
0.458 |
|
| 1996 |
Zhong Z, Pirofski LA. Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies Infection and Immunity. 64: 3446-3450. PMID 8751883 DOI: 10.1128/Iai.64.9.3446-3450.1996 |
0.516 |
|
| 1995 |
Deshaw M, Pirofski LA. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals Clinical and Experimental Immunology. 99: 425-432. PMID 7882565 DOI: 10.1111/J.1365-2249.1995.Tb05568.X |
0.456 |
|
| 1995 |
Pirofski L, Lui R, DeShaw M, Kressel AB, Zhong Z. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine Infection and Immunity. 63: 3005-3014. PMID 7622223 DOI: 10.1128/Iai.63.8.3005-3014.1995 |
0.518 |
|
| 1993 |
Mukherjee J, Pirofski LA, Scharff MD, Casadevall A. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proceedings of the National Academy of Sciences of the United States of America. 90: 3636-40. PMID 8475112 DOI: 10.1073/Pnas.90.8.3636 |
0.415 |
|
| 1993 |
Pirofski LA, Thomas EK, Scharff MD. Variable region gene utilization and mutation in a group of neutralizing murine anti-human immunodeficiency virus type 1 principal neutralizing determinant antibodies. Aids Research and Human Retroviruses. 9: 41-9. PMID 7678971 DOI: 10.1089/Aid.1993.9.41 |
0.389 |
|
| 1991 |
Pirofski L, Horwitz MS, Scharff MD, Factor SM. Murine adenovirus infection of SCID mice induces hepatic lesions that resemble human Reye syndrome. Proceedings of the National Academy of Sciences of the United States of America. 88: 4358-62. PMID 1852004 DOI: 10.1073/Pnas.88.10.4358 |
0.424 |
|
| 1990 |
Pirofski L, Casadevall A, Rodriguez L, Zuckier LS, Scharff MD. Current state of the hybridoma technology. Journal of Clinical Immunology. 10: 5S-12S; discussion 1. PMID 2081790 DOI: 10.1007/Bf00918686 |
0.433 |
|
| Show low-probability matches. |